D. E. Shaw & Co., Inc. - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2016$82,000
-70.9%
117,591
-17.1%
0.00%
-100.0%
Q2 2016$282,000
-9.6%
141,825
+9.5%
0.00%0.0%
Q1 2016$312,000
-44.9%
129,579
+75.7%
0.00%0.0%
Q4 2015$566,000
+98.6%
73,771
+37.1%
0.00%
Q3 2015$285,00053,7970.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2023
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders